Ashvin S, Regulatory Strategy/Regulatory Science at Kronos Bio

Ashvin S

Regulatory Strategy/Regulatory Science at Kronos Bio | San Francisco Bay Area, United States

Profile last verified July 2026
Biotechnology Verified Profile San Francisco Bay Area, United States University of Florida
Verified

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

312*****

United States • Mobile

Free account · No credit card · 5 profiles/month

Ashvin S Socials
Ashvin S Work Experience

Regulatory Strategy/Regulatory Science at Kronos Bio in July 2021 - Present

Senior Regulatory Affairs Specialist at Pharmacyclics, an AbbVie Company in March 2018 - July 2021

Regulatory Affairs Specialist at Cook Medical in January 2015 - March 2018

See more See less

Regulatory Affairs Specialist at Baxter International Inc. in August 2014 - January 2015

Graduate Research Assistant at College of Medicine at the University of Florida in March 2013 - July 2014

Internship at Vertex Pharmaceuticals in May 2012 - August 2012

Ashvin S Education

University of Florida, Master’s Degree

Anna University Chennai, Bachelor's degree

Ashvin S Skills
Medical Devices Pharmaceuticals 21 CFR Part 11 FDA GMP GCP GLP ISO 13485 ISO 14971 NDA IND Regulatory Affairs Quality Assurance Biomaterials Biotechnology Cardiovascular Disease Cardiovascular Devices Molecular Biology Microbiology CAPA FMEA Bioinformatics recombinant DNA technology HPLC Human Physiology Clinical Research Protein Purification Protein Expression Assay Development Animal Models Technical Presentations Cell Biology Clinical Trials GMP Gel Electrophoresis Protein Chemistry FDA Validation Cell Culture Quality Control Life Sciences Pharmacovigilance PCR Biochemistry Microsoft Office ICH-GCP SOP Pharmaceutical Industry Good Laboratory Practice (GLP) U.S. Food and Drug Administration (FDA) Regulatory Requirements
About Ashvin S’s Current Company
Kronos Bio

Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. At Kronos Bio, we have two molecules that have emerged from our product engine. KB-0742, our CDK9 inhibitor, is being evaluated in a phase 1/2 clinical trial as a treatment for patients with MYC-dependent tumors such as triple negative breast cancer, non-small cell lung cancer and ovarian cancer, as well as patients with transcription factor fusion-driven cancers and other transcriptionally addicted cancers including chordomas, sarcomas and small cell lung cancer. Our new development candidate, KB-9558, targets the KAT domain of p300, a critical node of the IRF4 TRN, which is a core oncogenic transcription program that drives multiple myeloma. Additionally, Kronos Bio began a discovery collaboration with Genentech in January 2023. Our companies are working together to advance novel therapies against transcriptional targets in oncology. For additional information about our community guidelines, visit: https://bit.ly/3FfcDQW.

Discover more about Kronos Bio
Ashvin S’s Colleagues
Charles Lin

Charles Lin

Cambridge, Massachusetts, United States

Sr. Vice President, Biology at Kronos Bio, Inc.

Research Fellow at Dana Farber Cancer Institute
(August 2026 – August 2026)

Gregory Julien

Gregory Julien

Sunnyvale, California, United States

Financial Planning & Corporate Development, Biotech

Director, Financial Planning & Analysis and Corporate Development at Kronos Bio
(June 2023 – November 2023)

Deepti Banka

Deepti Banka

Greater Boston

Patient-centric drug discovery enthusiast

Senior Scientist, Translational Development at Kronos Bio
(March 2023 – November 2023)

Crystal Mackenzie

Crystal Mackenzie

Greater Boston

Associate Director, Translation Operations at Kronos Bio, Inc.

Associate Director of Translation Operations at Kronos Bio, Inc.
(July 2021 – Present)

Jun Li

Jun Li

Cambridge, Massachusetts, United States

Senior Research Scientist at Kronos Bio, Inc.

Research Scientist II-Protein Characterizations at Charles River Laboratories
(August 2026 – August 2026)

Kameron Mori

Kameron Mori

Cambridge, Massachusetts, United States

In Vivo Pharmacology at Kronos Bio

Associate Scientist at Jounce Therapeutics, Inc.
(August 2026 – August 2026)

Search similar profiles
Frequently asked questions about Ashvin S

What is Ashvin S email address?

Email Ashvin S at [email protected] and [email protected]. This email is the most updated Ashvin S's email found in 2026.

What is Ashvin S phone number?

Ashvin S phone number is 3128605681.

How to contact Ashvin S?

To contact Ashvin S send an email to [email protected] or [email protected]. If you want to call Ashvin S try calling on 3128605681.

What company does Ashvin S work for?

Ashvin S works for Kronos Bio.

What is Ashvin S's role at Kronos Bio?

Ashvin S is Regulatory Strategy/Regulatory Science

What industry does Ashvin S work in?

Ashvin S works in the Biotechnology industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free